In ONM-500, OncoNano leverages its proprietary pH-sensitive micelle technology to deliver antigens while activating innate immunity for the treatment of cancers caused by the human papilloma virus (HPV).

Leveraging artificial intelligence & machine learning in the right way at the right time is key to our technology approach in R&D. Find out more from Tony Wood, SVP for Medicinal Science & Tech, and other experts on their real-world use of #AI. twitter.com/endpts/s…

Are you attending #GHC19 – the world’s largest gathering of women technologists? Stop by Stryker’s booth to learn more about our engineering opportunities & how you can work with products that are making healthcare & people’s lives better! bit.ly/2KICViN#WeAreStrykerpic.twitter.com/rFE1…